We would like to ensure that you are still receiving content that you find useful – please confirm that you would like to continue to receive ILO newsletters.
11 September 2019
On 28 June 2019 Health Canada released a revised Guidance Document: Administrative Processing of Submissions and Applications Involving Human or Disinfectant Drugs, effective immediately. The revisions include clarifying additions on the requirements for cross-licensed products for an administrative certification form and letter of authorisation, a drug notification form and labelling.
Health Canada has also released an updated Good Label and Package Practices Guide for Prescription Drugs. The 21 June 2019 update introduces only administrative edits to the 2016 guidance on the labelling and packaging of prescription pharmaceuticals, biologics and radiopharmaceuticals under Health Canada's Plain Language Labelling Initiative.
For further information on this topic please contact Lynn Ing at Smart & Biggar by telephone (+1 416 593 5514) or email (email@example.com). The Smart & Biggar website can be accessed at www.smart-biggar.ca.
The materials contained on this website are for general information purposes only and are subject to the disclaimer.
ILO is a premium online legal update service for major companies and law firms worldwide. In-house corporate counsel and other users of legal services, as well as law firm partners, qualify for a free subscription.